LifeSteps Financial’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $507K | Sell |
7,340
-12
| -0.2% | -$828 | 0.35% | 47 |
|
2025
Q1 | $511K | Sell |
7,352
-34
| -0.5% | -$2.36K | 0.41% | 46 |
|
2024
Q4 | $635K | Sell |
7,386
-25
| -0.3% | -$2.15K | 0.49% | 40 |
|
2024
Q3 | $882K | Hold |
7,411
| – | – | 0.69% | 28 |
|
2024
Q2 | $1.06M | Hold |
7,411
| – | – | 0.87% | 26 |
|
2024
Q1 | $952K | Hold |
7,411
| – | – | 0.72% | 28 |
|
2023
Q4 | $767K | Buy |
7,411
+25
| +0.3% | +$2.59K | 0.68% | 31 |
|
2023
Q3 | $672K | Hold |
7,386
| – | – | 0.68% | 32 |
|
2023
Q2 | $598K | Buy |
7,386
+150
| +2% | +$12.1K | 0.59% | 37 |
|
2023
Q1 | $576K | Hold |
7,236
| – | – | 0.61% | 35 |
|
2022
Q4 | $490K | Hold |
7,236
| – | – | 0.51% | 41 |
|
2022
Q3 | $360K | Hold |
7,236
| – | – | 0.41% | 49 |
|
2022
Q2 | $403K | Hold |
7,236
| – | – | 0.42% | 48 |
|
2022
Q1 | $402K | Hold |
7,236
| – | – | 0.3% | 57 |
|
2021
Q4 | $405K | Sell |
7,236
-216
| -3% | -$12.1K | 0.29% | 53 |
|
2021
Q3 | $358K | Hold |
7,452
| – | – | 0.27% | 56 |
|
2021
Q2 | $312K | Buy |
7,452
+216
| +3% | +$9.04K | 0.24% | 62 |
|
2021
Q1 | $244K | Hold |
7,236
| – | – | 0.2% | 77 |
|
2020
Q4 | $253K | Hold |
7,236
| – | – | 0.23% | 71 |
|
2020
Q3 | $251K | Hold |
7,236
| – | – | 0.26% | 62 |
|
2020
Q2 | $237K | Hold |
7,236
| – | – | 0.27% | 62 |
|
2020
Q1 | $218K | Hold |
7,236
| – | – | 0.25% | 68 |
|
2019
Q4 | $209K | Buy |
+7,236
| New | +$209K | 0.2% | 90 |
|